HOWL is in the clinic with both WTX-124 and WTX-330 and is set to report initial data from the phase 1 trial of WTX-124 in Q4'23. HOWL's partner JAZZ should file an Investigational New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback